AR219150A1 - Procedimiento para preparar nuevos derivados de aminoazucares - Google Patents

Procedimiento para preparar nuevos derivados de aminoazucares

Info

Publication number
AR219150A1
AR219150A1 AR275445A AR27544579A AR219150A1 AR 219150 A1 AR219150 A1 AR 219150A1 AR 275445 A AR275445 A AR 275445A AR 27544579 A AR27544579 A AR 27544579A AR 219150 A1 AR219150 A1 AR 219150A1
Authority
AR
Argentina
Prior art keywords
aminoazucar
derivatives
procedure
preparing new
preparing
Prior art date
Application number
AR275445A
Other languages
English (en)
Spanish (es)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AR219150A1 publication Critical patent/AR219150A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/99Enzyme inactivation by chemical treatment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AR275445A 1978-02-14 1979-02-08 Procedimiento para preparar nuevos derivados de aminoazucares AR219150A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB583478 1978-02-14

Publications (1)

Publication Number Publication Date
AR219150A1 true AR219150A1 (es) 1980-07-31

Family

ID=9803510

Family Applications (1)

Application Number Title Priority Date Filing Date
AR275445A AR219150A1 (es) 1978-02-14 1979-02-08 Procedimiento para preparar nuevos derivados de aminoazucares

Country Status (26)

Country Link
US (1) US4273765A (xx)
EP (1) EP0003616B1 (xx)
JP (1) JPS54163511A (xx)
AR (1) AR219150A1 (xx)
AT (1) AT367451B (xx)
AU (1) AU527318B2 (xx)
CA (1) CA1121290A (xx)
DE (2) DE2905649A1 (xx)
DK (1) DK149599C (xx)
ES (1) ES477653A1 (xx)
FI (1) FI63062C (xx)
FR (1) FR2416901A1 (xx)
GR (1) GR72817B (xx)
HU (1) HU181442B (xx)
IE (1) IE47916B1 (xx)
IL (1) IL56626A0 (xx)
LU (1) LU80906A1 (xx)
MC (1) MC1253A1 (xx)
NL (1) NL7901182A (xx)
NO (1) NO153011C (xx)
NZ (1) NZ189625A (xx)
PH (1) PH15084A (xx)
PT (1) PT69218A (xx)
SE (1) SE7901276L (xx)
YU (1) YU41437B (xx)
ZA (1) ZA79528B (xx)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3166093D1 (en) * 1981-01-05 1984-10-18 Takeda Chemical Industries Ltd N-substituted pseudo-aminosugars, their production and use
JPS57146713A (en) * 1981-03-09 1982-09-10 Akira Endo Hypoglycemic
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same
US4762857A (en) * 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4678812A (en) * 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4885361A (en) * 1987-07-31 1989-12-05 Hoffmann-La Roche Inc. Sulfated oligosaccharides
ATE132269T1 (de) * 1990-11-30 1996-01-15 Monoclonetics Int Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
PT1157696E (pt) * 2000-05-24 2007-01-31 Pfizer Tratamento da acidose ruminal com inibidores da alfa-amilase
US7022684B2 (en) * 2000-05-24 2006-04-04 Pfizer Inc. Treatment of rumen acidosis with α-amylase inhibitors
KR20060109926A (ko) 2003-11-19 2006-10-23 메타베이시스 테라퓨틱스, 인크. 새로운 인-함유 갑상선 호르몬 모방약들
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
ATE439347T1 (de) * 2004-11-23 2009-08-15 Warner Lambert Co 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptansäure- derivate als hmg-co-a-reductase-inhibitoren zur behandlung von lipidemia
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
BRPI0911063A2 (pt) 2008-04-11 2016-11-01 Astellas Pharma Inc composto aminoaçúcar e processo para produção do mesmo
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
CA2799708A1 (en) 2010-05-21 2011-11-24 Pfizer Inc. 2-phenyl benzoylamides
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US20130345392A1 (en) 2011-03-04 2013-12-26 Pfizer Inc Edn3-like peptides and uses thereof
MY188344A (en) 2012-03-09 2021-12-01 Biotropics Malaysia Berhad Extract formulations of rhodamnia cinerea and uses thereof
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
SG11201507496UA (en) 2013-04-17 2015-11-27 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
PT3004138T (pt) 2013-06-05 2024-06-18 Bausch Health Ireland Ltd Agonistas ultrapuros de guanilato ciclase c, método de produção e utilização dos mesmos
CA2959208C (en) 2014-08-29 2023-09-19 Tes Pharma S.R.L. Pyrimidine derivatives and their use as inhibitors of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
EP3526199B1 (en) 2016-10-14 2022-04-13 Tes Pharma S.r.l. Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
CA3119509A1 (en) 2018-11-20 2020-05-28 Tes Pharma S.R.L Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxxylase
SG11202107614PA (en) 2019-01-18 2021-08-30 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2064092C2 (de) * 1970-12-28 1983-06-01 Bayer Ag, 5090 Leverkusen Inhibitoren für Glykosidhydrolasen aus Actinomyceten
DE2347782C3 (de) * 1973-09-22 1979-10-11 Bayer Ag, 5090 Leverkusen Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
USRE29903E (en) 1975-03-19 1979-02-06 American Cyanamid Company Antibacterial antibiotics AM31α, AM31β and AM31γ
DE2614393C3 (de) * 1976-04-02 1980-04-03 Bayer Ag, 5090 Leverkusen Aminozucker-Derivate und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
SE7901276L (sv) 1979-08-15
PH15084A (en) 1982-07-02
AU527318B2 (en) 1983-02-24
MC1253A1 (fr) 1980-01-14
YU34879A (en) 1983-01-21
FI790486A (fi) 1979-08-15
DE2962165D1 (en) 1982-03-25
YU41437B (en) 1987-06-30
ZA79528B (en) 1980-02-27
PT69218A (en) 1979-03-01
FI63062C (fi) 1983-04-11
FI63062B (fi) 1982-12-31
NL7901182A (nl) 1979-08-16
IE790274L (en) 1979-08-14
NZ189625A (en) 1981-05-01
JPS54163511A (en) 1979-12-26
NO153011C (no) 1986-01-02
EP0003616A2 (de) 1979-08-22
DK149599C (da) 1987-06-01
DE2905649A1 (de) 1979-08-16
AT367451B (de) 1982-07-12
LU80906A1 (de) 1980-09-24
IE47916B1 (en) 1984-07-25
EP0003616A3 (en) 1979-09-05
FR2416901B1 (xx) 1980-10-24
ES477653A1 (es) 1980-03-01
DK149599B (da) 1986-08-04
IL56626A0 (en) 1979-05-31
FR2416901A1 (fr) 1979-09-07
HU181442B (en) 1983-07-28
NO153011B (no) 1985-09-23
NO790469L (no) 1979-08-15
US4273765A (en) 1981-06-16
DK61179A (da) 1979-08-15
GR72817B (xx) 1983-12-06
AU4402879A (en) 1979-08-23
JPS643877B2 (xx) 1989-01-23
ATA108879A (de) 1981-11-15
CA1121290A (en) 1982-04-06
EP0003616B1 (de) 1982-02-24

Similar Documents

Publication Publication Date Title
AR219150A1 (es) Procedimiento para preparar nuevos derivados de aminoazucares
ES497884A0 (es) Procedimiento para preparar derivados de 2-amino-4-hidroxi- quinazolina
MX5973E (es) Procedimiento para preparar compuestos cefem
AR225143A1 (es) Procedimiento para preparar derivados de fenil-metil-hidantoina
MX5880E (es) Procedimiento para preparar derivados de bencilimidazol
ES490504A0 (es) Procedimiento para preparar nuevos compuestos de tiadiazoli-lo
ES488593A0 (es) Procedimiento para preparar derivados de ciclopropano
ES488635A0 (es) Procedimiento para preparar derivados de pirimidina
ES494119A0 (es) Procedimiento para preparar derivados de 3-aminoproxiarilo
MX5399E (es) Procedimiento para preparar derivados de propanona
ES492032A0 (es) Procedimiento para preparar compuestos de cefem
ES488772A0 (es) Procedimiento para preparar derivados de pirimidona
AR226694A1 (es) Procedimiento para obtener nuevos derivados de antraciclina
AR224784A1 (es) Procedimiento para la preparacion de nuevos derivados de 4-amino-2-piperidinoquinazolina
MX151851A (es) Procedimiento mejorado para preparar derivados de triacina
MX6291E (es) Procedimiento para preparar derivados de n-bencilhalogenoacetamida
MX5724E (es) Procedimiento para preparar metil eteres de cetoximas sustituidas
MX5160E (es) Procedimiento mejorado para preparar derivados de aminoalcoholes
MX6971E (es) Procedimiento para preparar derivados de tetrahidroquinolina
ES492394A0 (es) Procedimiento para preparar derivados de pirimidina
AR228020A1 (es) Procedimiento para preparar derivados de 2-benciliden-benzofuran-3-ona
AR223161A1 (es) Procedimiento para preparar n-etiletilendiamina
ES492692A0 (es) Procedimiento para preparar derivados de benoimidazol
AR223177A1 (es) Procedimiento para preparar derivados de indolo-isoquinolina
MX150040A (es) Procedimiento mejorado para preparar 3-metil-ciclopentadecanona